ZA200101699B - An improved process for the preparation of thiazolidine-2,4-dione derivatives. - Google Patents

An improved process for the preparation of thiazolidine-2,4-dione derivatives. Download PDF

Info

Publication number
ZA200101699B
ZA200101699B ZA200101699A ZA200101699A ZA200101699B ZA 200101699 B ZA200101699 B ZA 200101699B ZA 200101699 A ZA200101699 A ZA 200101699A ZA 200101699 A ZA200101699 A ZA 200101699A ZA 200101699 B ZA200101699 B ZA 200101699B
Authority
ZA
South Africa
Prior art keywords
formula
reaction
dione
hours
compound
Prior art date
Application number
ZA200101699A
Other languages
English (en)
Inventor
Prabhakar Chebiyyam
Rajender Kumar Potlapally
Chinna Bakki Reddy Gade
Balaram Mahanti Satish
Ramabhadra Sarma Mamillapalli
Om Reddy Gaddam
Original Assignee
Reddy Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddy Research Foundation filed Critical Reddy Research Foundation
Publication of ZA200101699B publication Critical patent/ZA200101699B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA200101699A 1998-09-14 2001-02-28 An improved process for the preparation of thiazolidine-2,4-dione derivatives. ZA200101699B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2060MA1998 IN187716B (en, 2012) 1998-09-14 1998-09-14

Publications (1)

Publication Number Publication Date
ZA200101699B true ZA200101699B (en) 2002-05-28

Family

ID=11096874

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200101699A ZA200101699B (en) 1998-09-14 2001-02-28 An improved process for the preparation of thiazolidine-2,4-dione derivatives.

Country Status (24)

Country Link
US (1) US6469167B1 (en, 2012)
EP (1) EP1114047B1 (en, 2012)
JP (2) JP2002524563A (en, 2012)
KR (1) KR100448179B1 (en, 2012)
CN (2) CN1295222C (en, 2012)
AT (1) ATE234834T1 (en, 2012)
AU (1) AU762353B2 (en, 2012)
BR (1) BR9914493A (en, 2012)
CA (1) CA2343883C (en, 2012)
CZ (1) CZ300933B6 (en, 2012)
DE (1) DE69906100T2 (en, 2012)
DK (1) DK1114047T3 (en, 2012)
ES (1) ES2195600T3 (en, 2012)
HU (1) HU229519B1 (en, 2012)
IL (1) IL141737A0 (en, 2012)
IN (2) IN187716B (en, 2012)
NO (1) NO317383B1 (en, 2012)
NZ (1) NZ510316A (en, 2012)
PL (1) PL195617B1 (en, 2012)
PT (1) PT1114047E (en, 2012)
RU (1) RU2223961C2 (en, 2012)
UA (1) UA70962C2 (en, 2012)
WO (1) WO2000015638A1 (en, 2012)
ZA (1) ZA200101699B (en, 2012)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1487830A1 (en) * 2002-03-15 2004-12-22 Dr. Reddy's Laboratories Ltd. Novel crystalline form of 5-(4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)benzyl)thiazolidine-2,4-dione potassium salt
CN103288757B (zh) * 2013-05-16 2015-07-01 苏州明锐医药科技有限公司 6-氨基-7-羟基-3,4-二氢喹唑啉-4-酮的制备方法
KR101677340B1 (ko) 2014-11-28 2016-11-29 이청주 광고용 열기구
KR20160134615A (ko) 2016-11-11 2016-11-23 이청주 광고용 열기구
CN109867765A (zh) * 2019-02-28 2019-06-11 中山大学惠州研究院 一种长效缓释可降解防污聚氨酯及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB306228A (en) * 1927-12-15 1929-02-21 Bohn Aluminium & Brass Corp Improvements in pistons
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group P.L.C., Brentford Substituierte Thiazolidindionderivate
DE69132713D1 (de) * 1990-04-27 2001-10-11 Sankyo Co Benzylidenthiazolidinderivate, ihre Herstellung und ihre Anwendung als Lipidperoxid-Inhibitoren
DK0590793T3 (da) * 1992-08-31 2000-01-31 Sankyo Co Oxazolidin-derivater med anti-diabetiske og anti-obesitas-egenskaber, fremstilling deraf samt deres terapeutiske anvendelse
FR2696743B1 (fr) * 1992-10-12 1994-12-23 Adir Nouveaux composés de thiazolidine dione, leur procédé de préparation et les compositions pharmaceutiques les contenant.
TW399051B (en) * 1996-01-31 2000-07-21 Ssp Co Ltd A novel benzoazine thiazolidinedione derivative and pharmaceutical composition for reducing blood glucose
KR100579765B1 (ko) * 1996-07-01 2006-12-28 닥터 레디스 레보러터리즈 리미티드 신규헤테로고리형화합물의제조방법,이를함유하는약제조성물및당뇨병및이와관련된질병의치료에있어서그의용도
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
DK0958296T3 (da) * 1996-12-31 2003-08-18 Reddys Lab Ltd Dr Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme

Also Published As

Publication number Publication date
AU762353B2 (en) 2003-06-26
IN189187B (en, 2012) 2003-01-04
KR20010075088A (ko) 2001-08-09
IN187716B (en, 2012) 2002-06-15
US6469167B1 (en) 2002-10-22
KR100448179B1 (ko) 2004-09-10
HUP0103517A2 (hu) 2002-05-29
WO2000015638A1 (en) 2000-03-23
ES2195600T3 (es) 2003-12-01
NZ510316A (en) 2002-11-26
RU2223961C2 (ru) 2004-02-20
HUP0103517A3 (en) 2003-06-30
NO317383B1 (no) 2004-10-18
JP2011144179A (ja) 2011-07-28
PT1114047E (pt) 2003-07-31
PL346532A1 (en) 2002-02-11
PL195617B1 (pl) 2007-10-31
UA70962C2 (uk) 2004-11-15
DE69906100T2 (de) 2003-12-11
NO20011265L (no) 2001-05-14
CZ300933B6 (cs) 2009-09-16
CN1616439A (zh) 2005-05-18
DE69906100D1 (de) 2003-04-24
HU229519B1 (en) 2014-01-28
EP1114047B1 (en) 2003-03-19
NO20011265D0 (no) 2001-03-13
ATE234834T1 (de) 2003-04-15
CN1295222C (zh) 2007-01-17
CN1231481C (zh) 2005-12-14
BR9914493A (pt) 2001-06-26
HK1077814A1 (en) 2006-02-24
AU5439999A (en) 2000-04-03
CN1323305A (zh) 2001-11-21
CA2343883A1 (en) 2000-03-23
EP1114047A1 (en) 2001-07-11
JP2002524563A (ja) 2002-08-06
CZ2001825A3 (cs) 2001-08-15
CA2343883C (en) 2010-02-16
DK1114047T3 (da) 2003-06-23
IL141737A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
KR100249988B1 (ko) 티아졸리딘디온 유도체, 그의 제조방법 및 용도
Jouin et al. Stereospecific synthesis of N-protected statine and its analogues via chiral tetramic acid
US6875867B2 (en) Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
EP1114047B1 (en) An improved process for the preparation of thiazolidine-2,4-dione derivatives
KR20090119828A (ko) 4,4´-(1-메틸-1,2-에탄디일)-비스-(2,6-피페라진디온)의 신규 제조 방법
US7145017B2 (en) Preparation of Aztreonam
EP0242289B1 (fr) Procédé de préparation de dérivés d'oxazinobenzothiazine 6,6-dioxyde
EP0598765B1 (fr) Derive de l'amino-2 naphtyridine, sa preparation et son emploi
EP0146102B1 (en) Process for preparing benzothiazine compounds
CA2343194A1 (en) Substituted isoxazolylthiophene compounds
EP0271404B1 (fr) Nouveaux dérivés du pyrrole, leur préparation et les compositions pharmaceutiques qui les contiennent
EP1434870A1 (en) Enzymatic process for the preparation of substituted 2-amino-3-(2-amino-phenylsulfanyl)-propionic acid
JPH0557988B2 (en, 2012)
EP0412014A1 (fr) Dérivés benzothiaziniques, leur préparation et leurs applications comme médicaments ou comme intermédiaires de synthèse de médicaments
MXPA01002550A (en) An improved process for the preparation of thiazolidine-2,4-dione derivatives
KR0139260B1 (ko) 고리화된 이미다졸을 가지는 벤즈이미다졸 유도체
JP2520777B2 (ja) アリ―ルチオアルキルカルボン酸誘導体
JPH05148183A (ja) キノン誘導体の製造方法
JP4425373B2 (ja) ヒドロキシ−２−ハロゲノピリジン誘導体の製造方法
EP0522971A1 (fr) Un isomère dextrogyre d'un dérivé de amino-2 naphtyridine et son procédé pour son préparation
JPH11209345A (ja) 医薬品の中間体の製造方法
EP0761657A1 (en) Process for preparing benzyl-substituted rhodanine derivatives
JPS6165875A (ja) １，５−ベンゾチアゼピン誘導体の製法
JPH10158249A (ja) キナゾリノン誘導体
FR2533925A1 (fr) Hexahydro-1,2,3,6,7,10b thieno (3',2' : 3,4) pyrido (1,2-a) pyrazinones-4, et leur procede de preparation ainsi que leur activite anthelmintique